Personal Homepage

Personal Information

MORE+

Associate professor

Supervisor of Master's Candidates

Gender:Male

Education Level:博士研究生

Degree:Doctoral Degree in Science

Date of Employment:2015-07-16

School/Department:华侨大学医学院

E-Mail:

Status:在岗

Ma Junjie

+

Gender:Male

Education Level:博士研究生

Profile

MORE+

主要研究方向:

      针对肿瘤等重大疾病的临床需求,基于致病靶点的结构和机制,通过合理物设计、合成和评价,获得兼具良好成药性和生物活性的“候选药物分子”。


承担课程:现代仪器分析(色谱部分);药物化学;药物设计与合成。


科研项目(主持):

1.    泉州市高层次人才创新创业项目,2024QZC005YR2024/11-2027/10。

2. 福建省自然科学基金面上项目,2021J013092021/11-2024/11

3.      泉州市科技计划项目,2018C074R2018/08-2021-08

4.      华侨大学中青年教师科技创新资助计划,ZQN-PY5192017/10-2021/10

5.      福建省自然科学基金面上项目,2017J011432017/04-2020/04

6.      国家自然科学青年基金,816029702017/01-2019/12


科研论文

(第一作者/通讯作者)

1.   Yuan, Dandan; Gao, Yali; Xia, Lin; Liu, Han; Wu, Xingye; Ding, Xueyan; Huang, Yudan; Deng, Changchun; Li, Jin; Dai, Wenqi; Liu, JieqingMa, Junjie; Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors, Journal of Enzyme Inhibition and Medicinal Chemistry, 2025, 40(1): 2461190.

2.    He Li, Yali Gao, Xin Ni, Yizu Xiong, Peixi Zhang, Han Liu, Xingye Wu, Dandan Tong, Cuifang Wang & Junjie Ma. Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelators. Mol Divers, 2025, 29, 163-177. 

3.      X. Wu, H. Li, H. Liu, X. Ding, X. Chen, C. Yin, Y. Gao, J. Ma, Design, Synthesis and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists. ACS Medicinal Chemistry Letters, 2024, 15,  518523.

4.      Yali Gao*, Fei Li, Xin Ni, Siwang Yang, Han Liu, Xingye Wu, Jieqing Liu and Junjie Ma. Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat. RSC Adv., 2023,13, 28462-28480.

5.     Roufen Chen, Yali Gao, Han Liu, He Li, Wenfa Chen and Junjie Ma. Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020. RSC Med. Chem., 2023,14, 9-21.

6.     He Li, Yali Gao, and Junjie Ma. Advances in nonclassical phenyl bioisosteres for drug structural optimization. Future Medicinal Chemistry 2022 14, 1681-1692.

7.   Yu. Wang, Huang. Kun, Yali. Gao, Dandan. Yuan, Lin. Ling, Jieqing. Liu, Sihai. Wu, Roufen. Chen, He. Li, Yizu. Xiong, Han. Liu, Junjie. Ma, Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction, European Journal of Medicinal Chemistry, 2022, 229, 113998.

8.  Roufen Chen, Dandan Yuan, JunJie Ma, Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy, Future Med. Chem., 2022, 14(2), 97-113.

9.   Junjie Ma, Xin Ni, Yali Gao, Kun Huang, Jiaan liu, Yu Wang, Roufen Chen, Cuifang Wang*. Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3, MedChemComm, 2019, 10(3), 465-477.

10.  Junjie Ma, Xin Ni, Yali Gao, Kun Huang, Yu Wang, Jiaan Liu, Guowei Gong*. Semicarbazone derivatives bearing phenyl moiety: synthesis, anticancer activity, cell cycle, apoptosis-inducing and metabolic stability study, Chemical & Pharmaceutical Bulletin, 2019, 67(4), 351-360.

11.   Junjie Ma, Kun Huang, Xin Ni, Roufen Chen, Boxuan Xu & Cuifang Wang*. Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methyl-Biphenyl Moiety, Chem. Res. Chinese Universities, 2019, 35, 410-417.

12.  马俊杰倪欣黄坤王瑜含苯并噻唑/苯基片段的香豆素衍生物的设计、合成及抗肿瘤活性研究, Acta Pharmaceutica Sinica(药学学报), 2019, 54(3), 514 −521.

13.  倪欣黄坤马俊杰. Procaspase-3 小分子激活剂的研究进展中国现代应用药学, 2019, 36(3), 368-371.


(参与作者)

1.      Si-Hai Wu*, Rong Yang, Bin Sun, Jian-Hong Tang, Zhong-Liang Gong, Junjie Ma, Lianhui Wang, Jieqing Liu, Dian-Xue Ma, Jiang-Yang Shao*, and Yu-Wu Zhong*. Dual-Emissive Tris-Heteroleptic Ruthenium Complexes: Tuning the DNA-Triggered Ratiometric Emission Response by Ancillary Ligands. Inorg. Chem. 2021, 60, 19, 14810–14819.

2.      Si-Hai Wu*, Jiang-Yang Shao, Zifeng Zhao, Junjie Ma, Rong Yang, Na Chen, Jian-Hong Tang*, Zuqiang Bian, and Yu-Wu Zhong*. Ligand Engineering toward Deep Blue Emission in Nonplanar Terdentate Platinum(II) Complexes. Organometallics 2021, 40, 2, 156–165.

3.      Shao, Jiang-Yang; Wu, Si-Hai; Ma, Junjie; Gong, Zhong-Liang; Sun, Tian-Ge; Jin, Yulong; Yang, Rong; Sun, Bin; Zhong, Yu-Wu. Ratiometric detection of amyloid-beta aggregation by a dual-emissive tris-heteroleptic ruthenium complex, Chem. Commun., 2020, 56, 2087-2090.

4.      Jie-Qing Liu*, Ying Xu, Qin Xiao, Jin-Di Huang, Jun-Jie Ma, Chen-Lei Lian, Mei-Ying Huang, Zhen-bo Du and Cui-Fang Wang*, Dimericursones A and B: two unprecedented hexacyclic dimeric diterpenoids from the root barks of Jatropha curcas, Org. Biomol. Chem., 2018,16, 8305-8310.


授权专利:

1.      马俊杰,刘接卿,袁丹丹,陈柔芬,一种含异羟肟酸结构的联苯类化合物及其应用,ZL 202211121782.5.

2.      马俊杰,王瑜,陈柔棻,刘接卿,吴四海,一种苯并芳杂环化合物及其用途,ZL 202110222639. 4.

3.      马俊杰倪欣一种吲哚类衍生物及其应用, ZL 201911217790.8.

4.      马俊杰黄坤倪欣陈柔棻余楚丹闫琦慧陈思颖侯晓林一种香豆素类衍生物及其应用, ZL 201811131802.0.

5.      马俊杰黄坤王翠芳一种用作caspase-3激活剂的香豆素类衍生物及其应用, ZL 201810631499.4.


硕士研究生培养情况:

倪欣:国家奖学金、三好学生、承志英才新生奖学金、二等学业奖学金、华侨大学互联网+”大学生创新创业大赛主赛道创意组铜奖、26挑战杯华侨大学学生课外学术科技作品竞赛中获得二等奖、福建省创青春大赛优秀奖。

黄坤:华侨大学互联网+”大学生创新创业大赛主赛道创意组铜奖、三等学业奖学金、二等学业奖学金。

陈柔棻:攻读浙江大学博士、华侨大学优秀毕业生、华侨大学大学生标兵(校长特别奖)、教育部台湾学生奖学金-特等奖、华侨大学港澳台侨研究生奖学金-特等奖、华侨大学优秀学生干部、教育部以青春之志 筑强国之路主题征文一等奖、福建省台湾学生专项奖学金、华侨大学港澳台侨优秀研究生承志英才奖学金。

李贺:攻读河南大学博士。

刘寒:华侨大学优秀毕业生、校优秀学生2次,华侨大学学生社区优秀学生骨干。

  • Educational Experience
  • Work Experience

[1]  2012.9 to 2015.7
沈阳药科大学  | 药物化学  | Doctoral degree  | 博士研究生

[1]   2020.1 to  Now
华侨大学  | 医学院  | 副教授
[2]   2015.7  to  2019.12
华侨大学  | 医学院  | 讲师